Euro-QoL | SF-36 (physical health score) | SF-36 (mental health score) | |||||||
---|---|---|---|---|---|---|---|---|---|
Standard coefficient | Regression coefficient (95% CI) | p Value | Standard coefficient | Regression coefficient (95% CI) | p Value | Standard coefficient | Regression coefficient (95% CI) | p Value | |
Smoker | 0.13 | 1.38 (0.69 to 2.07) | <0.001 | −0.14 | −4.89 (−7.24 to −2.54) | <0.001 | −0.14 | −5.90 (−8.99 to −2.81) | <0.001 |
Caucasian race | NS | NS | – | 0.11 | 6.09 (2.21 to 9.98) | 0.002 | 0.12 | 8.17 (3.01 to 13.31) | 0.002 |
Male sex | −0.18 | −1.73 (−2.40 to −1.06) | <0.001 | 0.13 | 4.37 (2.08 to 6.66) | <0.001 | 0.11 | 4.38 (1.37 to 7.39) | 0.004 |
HLA-B27 positivity | NS | NS | – | NS | NS | – | NS | NS | – |
Drinker | NS | NS | – | NS | NS | – | NS | NS | – |
ASDAS–CRP | 0.52 | 2.47 (2.15 to 2.80) | <0.001 | −0.52 | −8.32 (−9.41 to −7.21) | <0.001 | −0.46 | −9.08 (−10.52 to −7.63) | <0.001 |
MRI sacroiliac joint inflammation | −0.12 | −1.26 (−1.96 to −0.56) | <0.001 | 0.14 | 4.94 (2.56 to 7.32) | <0.001 | 0.13 | 5.33 (2.20 to 8.46) | 0.001 |
BASMI | 0.12 | 0.56 (0.26 to 0.86) | <0.001 | −0.09 | −1.42 (−2.45 to −0.39) | 0.01 | NS | NS | – |
ASDAS–CRP, ankylosing spondylitis disease activity score, C-reactive protein based; BASMI, Bath ankylosing spondylitis metrology index; Euro-QoL, Euro-quality of life questionnaire; HLA, human leucocyte antigen; NI, not included in the multivariate model; NS, non-significant in multivariate analysis; SF-36, short form 36.